13/07/2022

NIH grants Nanokide

The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program

Read More
11/07/2022

Toribio Echevarria Awards

Nanokide has been awarded as a finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.

Read More
16/09/2022

Cantábrico Excelente Awards

Nanokide Therapeutics has been nominated in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.

Read More
20/07/2022

"Our nanoparticle blocks tumor growth"

Interview in the newspaper Berria

Read More